PharmiWeb.com - Global Pharma News & Resources

Biotech - Press Releases

Date Title Company
02-Nov-2020 DURECT Corporation Announces Third Quarter 2020 Financial Results and Update of Programs DURECT Corporation
02-Nov-2020 Dynavax to Present at the Stifel 2020 Virtual Healthcare Conference Dynavax Technologies
02-Nov-2020 Precigen to Announce Third Quarter 2020 Financial Results on November 9th: Will host Pipeline and Data Update Call in Early December Precigen, Inc.
02-Nov-2020 Syndax Pharmaceuticals Reports Third Quarter 2020 Financial Results and Provides Clinical and Business Update Syndax Pharmaceuticals, Inc.
02-Nov-2020 CTI BioPharma to Report Third Quarter 2020 Financial Results on November 10, 2020 CTI BioPharma Corp.
02-Nov-2020 DURECT Corporation Appoints Dr. Norman Sussman as Chief Medical Officer DURECT Corporation
02-Nov-2020 Curis to Release Third Quarter 2020 Financial Results and Hold Conference Call on November 10, 2020 Curis, Inc.
02-Nov-2020 Bachem Group Webinar on Cost-efficient and Green Manufacturing of Peptides thanks to Molecular Hiving™ Technology announced  SMi Group
02-Nov-2020 Nurami Medical Raises up to $6 Million Round in Series B Funding Led by Almeda Ventures Nurami Medical
02-Nov-2020 WCG Appoints Two New Independent Directors to its Board WCG
02-Nov-2020 Chi-Med to Attend Upcoming Industry and Investor Virtual Conferences Chi-Med
02-Nov-2020 United Therapeutics Corporation To Present At The Credit Suisse 29th Annual Virtual Healthcare Conference United Therapeutics Corporation
02-Nov-2020 Robocath finalizes creation of the joint venture with MicroPort through its medical robotic subsidiary MedBot Andrew Lloyd Associates
02-Nov-2020 Olympus Announces Acquisition of FH ORTHO Olympus
02-Nov-2020 Corlieve Therapeutics SAS Closes Seed Financing to Develop Therapies for Severe Neurological Conditions Corlieve Therapeutics
01-Nov-2020 TaiGen Announces FDA Approval of IND for Its Flu Antiviral TG-1000 TaiGen
31-Oct-2020 EADV 2020: Lilly and Incyte Showcase New Data for Baricitinib for the Treatment of Moderate to Severe Atopic Dermatitis Eli Lilly and Company
31-Oct-2020 Bimekizumab Phase 3 Data Shows Superior Skin Clearance Over Humira® in Moderate-to-Severe Psoriasis Patients UCB, Inc.
31-Oct-2020 Lesaffre and Recombia Biosciences to advance innovative gene editing technology through a strategic partnership Recombia Biosciences
30-Oct-2020 GNC Completes Chapter 11 Plan Process GNC Holdings, LLC